Afficher la notice abrégée

Real-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple Sclerosis

dc.contributor.authorBarrero Hernández, Francisco Javier 
dc.contributor.authorRomero Villarubia, Ana
dc.contributor.authorMuñoz Fernández, Carmen
dc.contributor.authorGuillen Martinez, Virginia
dc.contributor.authorAguilera Del Moral, Almudena
dc.contributor.authorBarrios-López, José María
dc.contributor.authorRamirez Rivas, Maria Ángeles
dc.contributor.authorGálvez Muñoz, Antonio Jesus
dc.contributor.authorPiñar Morales, Raquel 
dc.date.accessioned2024-07-01T07:22:00Z
dc.date.available2024-07-01T07:22:00Z
dc.date.issued2024-06-27
dc.identifier.citationBarrero Hernández, F.J.; Romero Villarrubia, A.; Muñoz Fernández, C.; Guillén Martinez, V.; Aguilera Del Moral, A.; Barrios-López, J.M.; Ramírez Rivas, M.A.; Gálvez Muñoz, A.J.; Piñar Morales, R. Real-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple Sclerosis. J. Pers. Med. 2024, 14, 692. https://doi.org/ 10.3390/jpm14070692es_ES
dc.identifier.urihttps://hdl.handle.net/10481/92888
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleReal-World Study of Serum Neurofilament Light Chain Levels in Ocrelizumab-Treated People with Relapsing Multiple Sclerosises_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.type.hasVersionVoRes_ES


Fichier(s) constituant ce document

[PDF]
Nom:
jpm-14-00692-v2.pdf
Taille:
1002.Ko
Format:
PDF

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepté là où spécifié autrement, la license de ce document est décrite en tant que Attribution-NonCommercial-NoDerivatives 4.0 Internacional